• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部晚期直肠癌术前放化疗及根治性手术后的及时肿瘤反应分析:一项关于直肠癌最佳手术时机的多机构研究

Timely tumor response analysis after preoperative chemoradiotherapy and curative surgery in locally advanced rectal cancer: A multi-institutional study for optimal surgical timing in rectal cancer.

作者信息

Kwak Yoo-Kang, Kim Kyubo, Lee Jong Hoon, Kim Sung Hwan, Cho Hyeon Min, Kim Dae Yong, Kim Tae Hyun, Kim Sun Young, Baek Ji Yeon, Oh Jae Hwan, Nam Taek Keun, Yoon Mee Sun, Jeong Jae Uk, Chie Eui Kyu, Jang Hong Seok, Kim Jae Sung

机构信息

Center for Colorectal Cancer, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Republic of Korea.

Department of Radiation Oncology, Seoul National University College of Medicine, Republic of Korea; Department of Radiation Oncology, Ewha Womans University School of Medicine, Republic of Korea.

出版信息

Radiother Oncol. 2016 Jun;119(3):512-8. doi: 10.1016/j.radonc.2016.03.017. Epub 2016 Apr 19.

DOI:10.1016/j.radonc.2016.03.017
PMID:27106552
Abstract

BACKGROUND AND PURPOSE

The definite surgical timing in rectal cancer after preoperative chemoradiotherapy (CRT) has not yet been fully examined. We assess the tumor response and identify the optimal operation timing after preoperative CRT in rectal cancer.

METHODS AND MATERIALS

The study included data of 1786 patients with locally advanced rectal cancer (cT3-4N0-2M0). They received preoperative CRT followed by total mesorectal excision. Total radiation dose was 50.4Gy in 28 fractions. Interval time between preoperative CRT and surgery ranged from 2 to 26weeks, with a median interval of 7.2weeks. Primary endpoint was to evaluate the period of highest downstaging and pathological complete response (ypCR) rates to determine the optimal timing for curative surgery after CRT.

RESULTS

Downstaging rates peaked between 6 and 7weeks after CRT and declined afterward. ypCR rates increased from 5 to 6weeks after CRT and decreased after 9 to 10weeks. Downstaging rates were similar between the two arms showing 36.9% in the early arm (⩽7weeks) and 37.0% in the delayed arm (>7weeks). ypCR rates were significantly higher in the delayed arm, as compared to the early arm (12.3% vs. 8.6%, p=0.011). The delayed arm had higher sphincter preservation rates than the early arm with a marginal significance (92.4% vs. 89.9%, p=0.078). There was no statistically significant difference regarding relapse-free survival and overall survival between the two arms.

CONCLUSIONS

ypCR rates increased after 5weeks and decreased after 10weeks and the delayed (>7weeks after CRT) group showed significantly increased ypCR rates than the early arm (⩽7weeks after CR). The optimal timing for curative surgery in rectal cancer when tumor response is maximal is after 7weeks and before 10weeks following preoperative CRT.

摘要

背景与目的

术前放化疗(CRT)后直肠癌的确切手术时机尚未得到充分研究。我们评估肿瘤反应并确定直肠癌术前CRT后的最佳手术时机。

方法与材料

本研究纳入了1786例局部晚期直肠癌(cT3 - 4N0 - 2M0)患者的数据。他们接受了术前CRT,随后进行全直肠系膜切除术。总放疗剂量为50.4Gy,分28次给予。术前CRT与手术之间的间隔时间为2至26周,中位间隔时间为7.2周。主要终点是评估最高降期和病理完全缓解(ypCR)率的时期,以确定CRT后根治性手术的最佳时机。

结果

降期率在CRT后6至7周达到峰值,之后下降。ypCR率在CRT后5至6周上升,9至10周后下降。两组的降期率相似,早期组(≤7周)为36.9%,延迟组(>7周)为37.0%。与早期组相比,延迟组的ypCR率显著更高(12.3%对8.6%,p = 0.011)。延迟组的括约肌保留率高于早期组,具有边缘显著性(92.4%对89.9%,p = 0.078)。两组之间的无复发生存率和总生存率无统计学显著差异。

结论

ypCR率在5周后上升,10周后下降,延迟组(CRT后>7周)的ypCR率显著高于早期组(CRT后≤7周)。当肿瘤反应最大时,直肠癌根治性手术的最佳时机是在术前CRT后7周之后、10周之前。

相似文献

1
Timely tumor response analysis after preoperative chemoradiotherapy and curative surgery in locally advanced rectal cancer: A multi-institutional study for optimal surgical timing in rectal cancer.局部晚期直肠癌术前放化疗及根治性手术后的及时肿瘤反应分析:一项关于直肠癌最佳手术时机的多机构研究
Radiother Oncol. 2016 Jun;119(3):512-8. doi: 10.1016/j.radonc.2016.03.017. Epub 2016 Apr 19.
2
Carcinoembryonic antigen has prognostic value for tumor downstaging and recurrence in rectal cancer after preoperative chemoradiotherapy and curative surgery: A multi-institutional and case-matched control study of KROG 14-12.癌胚抗原对直肠癌术前放化疗及根治性手术后的肿瘤降期和复发具有预后价值:KROG 14-12多机构病例匹配对照研究
Radiother Oncol. 2015 Aug;116(2):202-8. doi: 10.1016/j.radonc.2015.07.049. Epub 2015 Aug 21.
3
Two-week course of preoperative chemoradiotherapy followed by delayed surgery for rectal cancer: a phase II multi-institutional clinical trial (KROG 11-02).直肠癌术前放化疗两周疗程后延迟手术:一项II期多机构临床试验(KROG 11-02)
Radiother Oncol. 2014 Jan;110(1):150-4. doi: 10.1016/j.radonc.2013.11.013. Epub 2014 Jan 7.
4
Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategies.新辅助放化疗后 cT3 直肠癌完全病理缓解患者的长期预后:对局部切除手术策略的影响。
Ann Surg Oncol. 2011 Dec;18(13):3686-93. doi: 10.1245/s10434-011-1822-0. Epub 2011 Jun 21.
5
[Effects of neoadjuvant chemoradiotherapy on the rates of sphincter preserving surgery in lower rectal cancer and analysis of their prognostic factors].[新辅助放化疗对低位直肠癌保肛手术率的影响及其预后因素分析]
Zhonghua Wai Ke Za Zhi. 2016 Jun 1;54(6):419-423. doi: 10.3760/cma.j.issn.0529-5815.2016.06.005.
6
Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.局部晚期直肠癌术前放化疗后的最佳手术时间
Ann Surg. 2008 Aug;248(2):243-51. doi: 10.1097/SLA.0b013e31817fc2a0.
7
Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer.比较卡培他滨术前和术后放化疗治疗局部进展期直肠癌的随机 3 期临床试验。
Cancer. 2011 Aug 15;117(16):3703-12. doi: 10.1002/cncr.25943. Epub 2011 Feb 15.
8
The Impact of Surgical Timing on Pathologic Tumor Response after Short Course and Long Course Preoperative Chemoradiation for Locally Advanced Rectal Adenocarcinoma.短程和长程术前放化疗治疗局部进展期直肠腺癌后手术时机对病理肿瘤反应的影响。
Cancer Res Treat. 2018 Jul;50(3):1039-1050. doi: 10.4143/crt.2017.252. Epub 2017 Nov 21.
9
Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10-01 and 11-02.直肠癌术前放化疗后磁共振成像对病理分期的预测:KROG 10-01和11-02的汇总分析
Radiother Oncol. 2014 Oct;113(1):18-23. doi: 10.1016/j.radonc.2014.08.016. Epub 2014 Sep 19.
10
Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study.磁共振成像定义的局部进展期直肠癌的同期放化疗后手术和辅助卡培他滨加奥沙利铂(CAPOX)与诱导 CAPOX 后同期放化疗和手术的随机 II 期研究:Grupo cancer de recto 3 研究。
J Clin Oncol. 2010 Feb 10;28(5):859-65. doi: 10.1200/JCO.2009.25.8541. Epub 2010 Jan 11.

引用本文的文献

1
Total Lesion Glycolysis (TLG) on 18F-FDG PET/CT as a Potential Predictor of Pathological Complete Response in Locally Advanced Rectal Cancer After Total Neoadjuvant Therapy: A Retrospective Study.18F-FDG PET/CT上的总病变糖酵解(TLG)作为局部晚期直肠癌新辅助治疗后病理完全缓解的潜在预测指标:一项回顾性研究
Diagnostics (Basel). 2025 Jul 16;15(14):1800. doi: 10.3390/diagnostics15141800.
2
Delayed surgery for more than 9 weeks induces worse survival outcomes in locally advanced rectal cancer patients with poor response to neoadjuvant chemoradiotherapy: a propensity score matched cohort study.对于新辅助放化疗反应不佳的局部晚期直肠癌患者,延迟手术超过9周会导致更差的生存结果:一项倾向评分匹配队列研究。
Gastroenterol Rep (Oxf). 2025 Jul 2;13:goaf060. doi: 10.1093/gastro/goaf060. eCollection 2025.
3
Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy: A Secondary Analysis of the OPRA Randomized Clinical Trial.总新辅助治疗的直肠癌患者临床反应分级的器官保存和生存:OPRA 随机临床试验的二次分析。
JAMA Netw Open. 2024 Jan 2;7(1):e2350903. doi: 10.1001/jamanetworkopen.2023.50903.
4
Optimizing the Personalized Care for the Management of Rectal Cancer: A Consensus Statement.优化直肠癌管理的个性化护理:共识声明。
Turk J Gastroenterol. 2022 Aug;33(8):627-663. doi: 10.5152/tjg.2022.211103.
5
Effect of pathological complete response after neoadjuvant chemoradiotherapy on postoperative complications of rectal cancer: a systematic review and meta-analysis.新辅助放化疗后病理完全缓解对直肠癌术后并发症的影响:系统评价和荟萃分析。
Tech Coloproctol. 2022 Mar;26(3):163-174. doi: 10.1007/s10151-021-02564-y. Epub 2022 Jan 20.
6
One to Two Cycles of Consolidation Chemotherapy With Capecitabine After Neoadjuvant Chemoradiotherapy Does Not Benefit Low-Risk Patients With Locally Advanced Middle-Low Rectal Cancer.新辅助放化疗后使用卡培他滨进行一至两个周期的巩固化疗对局部晚期中低位直肠癌低风险患者无益处。
Front Oncol. 2021 Sep 30;11:695726. doi: 10.3389/fonc.2021.695726. eCollection 2021.
7
Adding Three Cycles of CAPOX after Neoadjuvant Chemoradiotherapy Increases the Rates of Complete Response for Locally Advanced Rectal Cancer.新辅助放化疗后加用 3 周期 CAPOX 可提高局部进展期直肠癌的完全缓解率。
Curr Oncol. 2021 Jan 6;28(1):283-293. doi: 10.3390/curroncol28010033.
8
Gastrointestinal Malignancies and the COVID-19 Pandemic: Evidence-Based Triage to Surgery.胃肠道恶性肿瘤与 COVID-19 大流行:基于证据的手术分诊。
J Gastrointest Surg. 2020 Oct;24(10):2357-2373. doi: 10.1007/s11605-020-04712-5. Epub 2020 Jun 30.
9
Optimal timing and treatment strategy for pancreatic cancer.胰腺癌的最佳时机和治疗策略。
J Surg Oncol. 2020 Sep;122(3):457-468. doi: 10.1002/jso.25976. Epub 2020 May 29.
10
Dose-time fractionation schedules of preoperative radiotherapy and timing to surgery for rectal cancer.直肠癌术前放疗的剂量-时间分割方案及手术时机
Ther Adv Med Oncol. 2020 Feb 29;12:1758835920907537. doi: 10.1177/1758835920907537. eCollection 2020.